Patents Assigned to Imagilin Technologies, LLC
  • Patent number: 8496923
    Abstract: An exemplary embodiment providing one or more improvements includes feeding animals with probiotic microbes encapsulated in a mixture of xanthan gum and chitosan, or in gelatin, specifically Pediococcus acidilactici and Saccharomyces boulardii. Such encapsulation protects the viability of the probiotic microbes against unfavorable temperatures. An exemplary embodiment providing one or more improvements includes methods of using viable probiotics in therapy of birds and mammals infected with infectious diseases. Probiotics acted as adjuvants in stimulating antibody reaction and stimulated a cellular immunity response. In particular, probiotics were shown to reduce the number of viable oocytes from fecal samples, stimulate antibody production, and stimulate of proliferation of splenocytes in chickens infected with Eimeria. In addition, probiotics were shown to relieve symptoms of parvovirus infection in dogs.
    Type: Grant
    Filed: November 2, 2010
    Date of Patent: July 30, 2013
    Assignee: Imagilin Technology, LLC.
    Inventor: Jhy-Jhu Lin
  • Patent number: 8318152
    Abstract: An exemplary embodiment providing one or more improvements includes probiotic compositions comprising probiotic microorganisms with dried vegetable, fruit, cereal, or herb powder. Feeding human or animals either having biological or environmental changes with probiotic compositions has a positive effect in relieving the changes. Positive effects has been demonstrated in humans, dogs, and fish.
    Type: Grant
    Filed: April 16, 2009
    Date of Patent: November 27, 2012
    Assignee: Imagilin Technology, LLC
    Inventor: Jhy-Jhu Lin
  • Patent number: 7935334
    Abstract: An exemplary embodiment providing one or more improvements includes feeding animals with probiotic microbes encapsulated in a mixture of xanthan gum and chitosan, or in gelatin, specifically Pediococcus acidilactici and Saccharomyces boulardii. Such encapsulation protects the viability of the probiotic microbes against unfavorable temperatures. An exemplary embodiment providing one or more improvements includes methods of using viable probiotics in therapy of birds and mammals infected with infectious diseases. Probiotics acted as adjuvants in stimulating antibody reaction and stimulated a cellular immunity response. In particular, probiotics were shown to reduce the number of viable oocytes from fecal samples, stimulate antibody production, and stimulate of proliferation of splenocytes in chickens infected with Elimeria. In addition, probiotics were shown to relieve symptoms of parvovirus infection in dogs.
    Type: Grant
    Filed: July 26, 2006
    Date of Patent: May 3, 2011
    Assignee: Imagilin Technologies, LLC
    Inventor: Jhy-Jhu Lin
  • Publication number: 20090263366
    Abstract: An exemplary embodiment providing one or more improvements includes probiotic compositions comprising probiotic microorganisms with dried vegetable, fruit, cereal, or herb powder. Feeding human or animals either having biological or environmental changes with probiotic compositions has a positive effect in relieving the changes. Positive effects has been demonstrated in humans, dogs, and fish.
    Type: Application
    Filed: April 16, 2009
    Publication date: October 22, 2009
    Applicant: Imagilin Technology, LLC
    Inventor: Jhy-Jhu Lin